68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer

被引：13
|
作者：
Aydin, Funda [1 ]
Akcal, Arzu [2 ]
Unal, Betul [3 ]
Goksu, Sema Sezgin [4 ]
Gungor, Firat [5 ]
机构：
[1] Akdeniz Univ, Dept Nucl Med, Antalya, Turkey
[2] Akdeniz Univ, Dept Plast Reconstruct & Aesthet Surg, Antalya, Turkey
[3] Akdeniz Univ, Dept Pathol, Antalya, Turkey
[4] Akdeniz Univ, Dept Med Oncol, Antalya, Turkey
[5] Emsey Hosp, Dept Nucl Med, Istanbul, Turkey
来源：
CLINICAL NUCLEAR MEDICINE | 2017年 / 42卷 / 05期
关键词：
Ga-68-PSMA PET/CT; dermatofibroma; PSMA; GA-68-LABELED PSMA LIGAND; HBED-CC; PET/CT; EXPRESSION; CARCINOMA; DIAGNOSIS;
D O I：
10.1097/RLU.0000000000001591
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Prostate-specific membrane antigen (PSMA) is a typ. 2 transmembrane protein that is highly expressed in prostate cancer cells. 68Ga-PSMA PET/CT imaging is a modality used to determine the extent of prostate cancer. Various other neoplasias may also express PSMA, which appears as 68Ga-PSMA uptake in PET/CT imaging. A 71-year-old man with prostate cancer underwent 68Ga-PSMA PET/CT imaging for restaging after having an elevated prostate-specific antigen level. Subcutaneous lesions showing focal PSMA uptake were detected, one of which was excised. The histopathologic diagnosis was dermatofibroma. © 2017 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码：358 / 360
页数：3
相关论文
共 50 条
  • [31] Impact of 68Ga-PSMA PET/CT in Staging of Prostate Cancer Patient Prior to Radiation Therapy
    Sterzing, F.
    Fiedler, H.
    Stefanova, M.
    Afshar-Oromieh, A.
    Kratochwil, C.
    Debus, J.
    Haberkorn, U.
    Giesel, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S449 - S449
  • [32] Comparison of 68Ga-PSMA and 64Cu-PSMA in Patients with Recurrent Prostate Cancer
    Villano, C.
    Sindona, E.
    Pigotti, G.
    Ferrari, C.
    Cascini, G.
    Bruno, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S542 - S542
  • [33] 68Ga-PSMA and 68Ga-DOTATOC PET/CT imaging mismatch of primary pancreatic adenocarcinoma in prostate cancer patient
    Manuela Bonacina
    Paolo Ghirardelli
    Lucia Setti
    Vittorio Vavassori
    Emilio Bombardieri
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 781 - 782
  • [34] Impact of 68Ga-PSMA PET for primary radiotherapy management of prostate cancer
    Karahissarlian, V.
    Pommier, P.
    Isnardi, V.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2019, 43 (03): : 280 - 283
  • [35] LCerebellar Metastases From Prostate Cancer on 68Ga-PSMA PET/CT
    Chan, Mico
    Hsiao, Edward
    Turner, Jennifer
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (03) : 193 - 194
  • [36] Late-Term Findings of Pancreatitis on 68Ga-PSMA PET/CT in a Patient With Prostate Cancer
    Tosunoglu, Zehranur
    Erol Fenercioglu, Ozge
    Beyhan, Ediz
    Arslan, Esra
    cermik, Tevfik Fikret
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (12) : E733 - E734
  • [37] Impact of 68Ga-PSMA PET/CT on Survival and Management in Prostate Cancer
    Algin, Efnan
    Okudan, Berna
    Acikgoz, Yusuf
    Sayan, Haluk
    Bal, Oznur
    Seven, Bedri
    CURRENT MEDICAL IMAGING, 2024, 20
  • [38] 68Ga-PSMA PET/CT; current impact on management in prostate cancer
    Intema, F.
    Kooistra, A.
    Lont, A. P.
    Hendriks, L. P. J.
    Esser, J. P.
    Lange, R.
    de Klerk, J. M. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S707 - S707
  • [39] Primary staging of prostate cancer using 68Ga-PSMA PET/CT
    Graziani, T.
    Scarlattei, M.
    Baldari, G.
    Migliari, S.
    Sammartano, A.
    Gasparro, D.
    Maestroni, U.
    Ruffini, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S599 - S600
  • [40] Asymptomatic Prostate Cancer Brain Metastases on 68Ga-PSMA PET/CT
    Yin, Charlotte
    Ho, Bao
    Chan, Lyn
    Emmett, Louise
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E382 - E384
12345